Sinopharm
1099.HK
$2.54
Share price
-1.78%
Change (1 day)
-28.25%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Total debt
Total debt on the balance sheet as of June 2023 : $13.07 B
According to Sinopharm's latest financial reports the company's total debt is $13.07 B. A company’s total debt is the sum of all current and non-current debts.
Sinopharm - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $13.70 B | 27.72% |
| 2021-12-31 | $10.72 B | 2.12% |
| 2020-12-31 | $10.50 B | 33.11% |
| 2019-12-31 | $7.89 B | -1.49% |
| 2018-12-31 | $8.01 B | 39.97% |
| 2017-12-31 | $5.72 B | 18.67% |
| 2016-12-31 | $4.82 B | 7.95% |
| 2015-12-31 | $4.46 B | -6.06% |
| 2014-12-31 | $4.75 B | 14.51% |
| 2013-12-31 | $4.15 B | 60.48% |
| 2012-12-31 | $2.58 B | 17.48% |
| 2011-12-31 | $2.20 B | 324.17% |
| 2010-12-31 | $0.51 B | 106.45% |
| 2009-12-31 | $0.25 B | 4.91% |
| 2008-12-31 | $0.23 B | -24.57% |
| 2007-12-31 | $0.31 B | 31.88% |
| 2006-12-31 | $0.24 B |